Literature DB >> 7581370

Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome.

A Rötig1, T Bourgeron, D Chretien, P Rustin, A Munnich.   

Abstract

The Pearson marrow-pancreas syndrome (MIM 557000) is a disorder involving the hematopoietic system and the exocrine pancreas in early infancy. We have previously shown that this disease results from a defect of oxidative phosphorylation associated with deletions of the mitochondrial DNA. We present here a series of 21 cases (including 15 unreported patients) with Pearson syndrome and describe mitochondrial DNA deletions as consistent features in this syndrome. Nine patients presented the same 4.9 kb deletion, while other patients presented different deletions ranging in size from 9 to 14 kb between tRNACyst and the D-loop. Direct repeats (4-13 bp) were consistently present in the wild-type mtDNA at the boundaries of the deletions. Deletion-dimers, deletion-multimers or duplications were observed in association with deletions. Duplications were identified both in patients who died of their Pearson syndrome and in the ones who survived and developed Kearns-Sayre syndrome, suggesting that no correlation could be made between the clinical severity and the type, size or location of the rearrangements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581370     DOI: 10.1093/hmg/4.8.1327

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  42 in total

1.  A family showing recessively inherited multisystem pathology with aberrant splicing of the erythrocyte Band 7.2b ('stomatin') gene.

Authors:  A C Argent; M C Chetty; B Fricke; Y Bertrand; N Philippe; S Khogali; M von Düring; J Delaunay; G W Stewart
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Pearson syndrome and the role of deletion dimers and duplications in the mtDNA.

Authors:  L J A M Jacobs; R J E Jongbloed; F A Wijburg; J B C de Klerk; J P M Geraedts; J G Nijland; H R Scholte; I F M de Coo; H J M Smeets
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

3.  The association between haematological manifestation and mtDNA deletions in Pearson syndrome.

Authors:  K Muraki; S Nishimura; Y Goto; I Nonaka; N Sakura; K Ueda
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

4.  Mitochondrial DNA spectra of single human CD34+ cells, T cells, B cells, and granulocytes.

Authors:  Yoji Ogasawara; Kazutaka Nakayama; Magdalena Tarnowka; J Philip McCoy; Sachiko Kajigaya; Barbara C Levin; Neal S Young
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

5.  A novel deletion in a Pearson syndrome infant with hypospadias and cleft lip and palate.

Authors:  O Lohi; A L Kuusela; M Arola
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Primary adrenal insufficiency in a child with a mitochondrial DNA deletion.

Authors:  C Bruno; C Minetti; Y Tang; P J Magalhães; F M Santorelli; S Shanske; M Bado; G Cordone; R Gatti; S DiMauro
Journal:  J Inherit Metab Dis       Date:  1998-04       Impact factor: 4.982

Review 7.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 8.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

9.  Pearson's syndrome without marrow involvement.

Authors:  A A Morris; P J Lamont; P T Clayton
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

10.  Detection of mitochondrial DNA deletions by a screening procedure using the polymerase chain reaction.

Authors:  T Ferlin; G Guironnet; M C Barnoux; R Dumoulin; G Stepien; B Mousson
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.